← Browse by Condition
Medical Condition
major depressive disorder
Total Trials
27
Recruiting Now
27
Trial Phases
Phase 2, Phase 3, Phase 2, Phase 3
NCT05809609
Recruiting
Glutamate Emotion Memory Study
Enrollment
60 pts
Location
United Kingdom
Sponsor
University of Oxford
NCT06529029 Phase 2, Phase 3
Recruiting
Low Amplitude Pulse Seizure Therapy Versus Standard Ultra-Brief Right Unilateral Electroconvulsive Therapy
Enrollment
30 pts
Location
United States
Sponsor
Michigan State University
NCT04637620 Phase 2
Recruiting
NMDA Modulation in Major Depressive Disorder
Enrollment
90 pts
Location
Taiwan
Sponsor
China Medical University Hospi...
NCT04041479 Phase 3
Recruiting
Biomarker-guided rTMS for Treatment Resistant Depression
Enrollment
348 pts
Location
United States
Sponsor
Weill Medical College of Corne...
NCT07276997 Phase 2
Recruiting
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
Enrollment
195 pts
Location
United States
Sponsor
AbbVie
NCT05384405
Recruiting
aiTBS for Relieving NSSI in Depressive Patients
Enrollment
60 pts
Location
China
Sponsor
Central South University
NCT05239780
Recruiting
Invasive Decoding and Stimulation of Altered Reward Computations in Depression Patients
Enrollment
10 pts
Location
United States
Sponsor
Icahn School of Medicine at Mo...
NCT06110897
Recruiting
RESISTance Exercise for Depression Trial
Enrollment
200 pts
Location
United States
Sponsor
University of Wisconsin, Madis...
NCT06860724
Recruiting
Linking Affective Dynamics in Response to Daily Stress to Peripheral Vascular Function in Working Age Adults
Enrollment
18 pts
Location
United States
Sponsor
University of Delaware
NCT05357040 Phase 2
Recruiting
Antidepressant Effects of Nitrous Oxide
Enrollment
172 pts
Location
United States, Austr...
Sponsor
University of Chicago
NCT03665831
Recruiting
Deep TMS for Comorbid Depression and Cognitive Impairment in Older Adults
Enrollment
28 pts
Location
Canada
Sponsor
Rotman Research Institute at B...
NCT07305701
Recruiting
Cohort Study on Medical Students' Mental Health
Enrollment
10,000 pts
Location
France
Sponsor
Centre Hospitalier Régional d'...
NCT06050070
Recruiting
Targeting Large-scale Networks in Depression With Real-time Functional Magnetic Resonance Imaging (fMRI) Neurofeedback
Enrollment
70 pts
Location
United States
Sponsor
University of Michigan
NCT06968390
Recruiting
Accelerated TMS for Perinatal Depression
Enrollment
24 pts
Location
United States
Sponsor
Brigham and Women's Hospital
NCT06086366
Recruiting
Presynaptic Imaging in Major Depressive Episodes After COVID-19
Enrollment
90 pts
Location
Canada
Sponsor
Centre for Addiction and Menta...
NCT05547035
Recruiting
Identification of Physiological Data by a Wearable Monitor in Subjects Suffering From Major Depression Disorders
Enrollment
200 pts
Location
France
Sponsor
Digital For Mental Health
NCT04685148 Phase 1, Phase 2
Recruiting
Maternal Mental Health Trial
Enrollment
220 pts
Location
Denmark
Sponsor
Vibe G Frøkjær, MD, PhD
NCT05913960
Recruiting
Accelerated Intermittent Theta-Burst Stimulation Ameliorate Major Depressive Disorder by Regulating CAMKII Pathway
Enrollment
90 pts
Location
China
Sponsor
First Affiliated Hospital of Z...
NCT04751331 Phase 1, Phase 2
Recruiting
Neural Response to Inflammatory Challenge in Major Depressive Disorder
Enrollment
180 pts
Location
United States
Sponsor
Laureate Institute for Brain R...
NCT06058039 Phase 3
Recruiting
Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive Disorder
Enrollment
332 pts
Location
United States, Bulga...
Sponsor
Neumora Therapeutics, Inc.
NCT03437928
Recruiting
DBS for Depression
Enrollment
12 pts
Location
United States
Sponsor
Baylor College of Medicine
NCT06350396
Recruiting
pBFS-guided rTMS Over DMPFC for Treatment-Resistant Depression
Enrollment
270 pts
Location
China
Sponsor
Changping Laboratory
NCT07204314 Phase 3
Recruiting
A Study of Vortioxetine in Japanese Pediatric Patients With Major Depressive Disorder
Enrollment
180 pts
Location
Japan
Sponsor
Takeda
NCT06547489 Phase 2
Recruiting
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Enrollment
164 pts
Location
United States
Sponsor
Syndeio Biosciences, Inc
NCT03748446 EARLY_Phase 1
Recruiting
Xenon Inhalation Therapy for Major Depressive Disorder and Bipolar Disorder
Enrollment
20 pts
Location
United States
Sponsor
Massachusetts General Hospital
NCT06183359
Recruiting
Self-Identification Program
Enrollment
86 pts
Location
France
Sponsor
University Hospital, Montpelli...
NCT06626152 Phase 2
Recruiting
Measuring Psychomotor Response to L-DOPA Challenge As a Biomarker for Outcomes in Late-Life Depression: a Pilot Feasibility Trial
Enrollment
50 pts
Location
Canada
Sponsor
University of British Columbia